AI illustration · not actual product photoDetails from the source.
Source-listed HCG (SKU G10K): 10000IU*10vials. PriceList(1).pdf lists 152 per 10 vials but does not specify currency; the website displays $152 per 10 vials in USD per owner instruction. The source row does not establish the supplier-specific item's identity, lot quality, or approval.
- Catalogue code
- G10K
- Source specification
- 10000IU*10vials
- Source document
- PriceList(1).pdf, page 3
- Photograph
- AI-generated illustration only — not an actual product photo or verified molecular depiction; owner-approved product photo still pending.
Product information is presented from supplied source materials. Inclusion on this website does not state that a product is an approved medicine or authorize human use. This is educational content, not medical advice.
Compound-level research and safety context.
Evidence below concerns the research family associated with this listing. For blends, findings about individual components do not establish evidence for the combination. This does not verify the supplier-specific vial or lot. Reviewed 2026-10-30.
What it is
The source-listed exact label is HCG. The catalogue lists G5K: *10vials, price 84 per 10 vials; and G10K: *10vials, price 152 per 10 vials. The source does not state currency. hCG is a glycoprotein/polypeptide hormone composed of peptide subunits, rather than a small peptide drug. These scientific descriptions identify the hormone generally, not the precise contents of either supplier vial.
Biological mechanism
hCG acts much like luteinizing hormone (LH) at the LH/choriogonadotropin receptor. It stimulates gonadal steroid production: testicular Leydig cells produce androgens and the ovarian corpus luteum produces progesterone. In reproductive physiology, hCG can substitute for the LH signal that triggers ovulation; product labels also describe a small degree of FSH-like activity. [1] [3]
Research focus
Research and product labeling concern reproductive endocrinology: selected cases of male hypogonadotropic hypogonadism, ovulation induction in selected patients receiving gonadotropin treatment, and prepubertal cryptorchidism not caused by anatomical obstruction are stated indications for named FDA-labeled products. Clinical literature also investigates gonadotropin treatment for fertility in men with congenital hypogonadotropic hypogonadism. These are not claims about the catalogue vials. [1] [2] [4]
Potential applications in the evidence
As investigated in humans and listed for specific FDA-labeled products, hCG has reproductive applications involving selected forms of hypogonadotropic hypogonadism, ovulation induction, and prepubertal cryptorchidism not caused by anatomical obstruction. Indications and eligibility are product- and patient-specific; this evidence does not establish an application for the supplier-specific items. [1] [2]
Human evidence
hCG has established hormone activity, and named FDA-labeled products have defined prescription indications. Human studies reviewed in the literature report spermatogenesis and fertility outcomes in male hypogonadotropic hypogonadism, but results vary with baseline testicular development and treatment regimens; many reports are clinical series. hCG alone appears less successful in men with little or no testicular development, and combination gonadotropin regimens have also been studied. This does not establish the identity, potency, quality, safety, or clinical performance of G5K or G10K. [1] [2] [4]
Known and potential effects
Product labeling reports headache, irritability, restlessness, depression, fatigue, edema, gynecomastia, precocious puberty, and injection-site pain. Serious reported or potential risks include hypersensitivity or anaphylaxis with urinary-derived products; ovarian hyperstimulation syndrome (which can be life-threatening); ovarian cyst rupture and bleeding; multiple gestation; and venous or arterial thromboembolism and pulmonary complications during gonadotropin treatment. [1] [2]
Safety and contraindications
Product-specific contraindications differ. Labels include hypersensitivity to gonadotropins and, depending on the product and indication, conditions involving endocrine function, reproductive organs, or tumors. Ovarian stimulation carries risks including OHSS, multiple gestation, and thromboembolism; named product labeling calls for clinical monitoring. These general label warnings cannot determine safety for the unidentified supplier vial. No treatment advice is provided. [1] [2]
U.S. FDA / regulatory status
U.S. FDA labeling exists for named prescription chorionic gonadotropin products. For example, DailyMed lists a Fresenius Kabi human prescription drug label with Biologic Licensing Application marketing status, and an FDA-hosted Pregnyl label covers that named product and its described formulation. Regulatory status of those named products does not transfer to a vial merely labelled HCG. The supplied catalogue does not identify its manufacturer, lot, formulation source, jurisdiction, or approval documentation; FDA approval or authorization of G5K or G10K cannot be verified. [1] [2]
Evidence limitations
The supplier price list is not a certificate of analysis or regulatory authorization. Published hCG studies and labels for named products cannot verify these specific vials' contents, sterility, potency, excipients, manufacturing controls, storage history, or safety. Do not transfer findings from a named drug product to these supplier-specific items. The listed price currency is also not stated in the source catalogue.
Supporting sources
- Chorionic Gonadotropin kit label, updated April 11, 2025 DailyMed, U.S. National Library of Medicine · U.S. prescription drug label / regulatory database. Supports: Hormone identity and subunits, mechanism, named product indications and label marketing status, contraindications, warnings, and adverse effects.
- Pregnyl chorionic gonadotropin for injection prescribing information U.S. Food and Drug Administration · FDA product label. Supports: Named product's formulation-specific description and indications; serious reproductive and vascular warnings and risks. Does not identify the catalogue item.
- Structure, Function and Regulation of Gonadotropin Receptors National Center for Biotechnology Information, PubMed Central · Peer-reviewed review. Supports: LH/choriogonadotropin receptor biology and mechanism.
- Gonadotrophin replacement for induction of fertility in hypogonadal men Best Practice & Research Clinical Endocrinology & Metabolism / ScienceDirect · Peer-reviewed clinical review. Supports: Human clinical evidence and its limitations in hypogonadotropic hypogonadism and fertility, including variable outcomes and treatment regimens.